| DIRECT COMPETITOR COMPARISON | |
| IDRA | ANDS | DVAX | PFE | Industry | | Market Cap: | 118.76M | 84.69M | 59.03M | 151.55B | N/A | | Employees: | 37 | 30 | 155 | 81,800 | N/A | | Qtrly Rev Growth (yoy): | -13.00% | N/A | -67.20% | -2.90% | N/A | | Revenue (ttm): | 30.52M | N/A | 50.07M | 45.82B | N/A | | Gross Margin (ttm): | 39.50% | N/A | 43.14% | 86.61% | N/A | | EBITDA (ttm): | 4.45M | -28.52M | 1.29M | 21.31B | N/A | | Oper Margins (ttm): | 12.62% | N/A | -3.21% | 37.42% | N/A | | Net Income (ttm): | 3.98M | -31.54M | 2.80M | 8.09B | N/A | | EPS (ttm): | 0.164 | -0.997 | 0.070 | 1.204 | N/A | | P/E (ttm): | 30.85 | N/A | 20.43 | 15.60 | N/A | | PEG (5 yr expected): | N/A | N/A | N/A | 5.99 | N/A | | P/S (ttm): | 3.90 | N/A | 1.19 | 3.28 | N/A |
|
| ANDS = Anadys Pharmaceuticals Inc. | | DVAX = Dynavax Technologies Corporation | | PFE = Pfizer Inc. | |
| NEWS ON DIRECT COMPETITORS | |
| | PFE | | [video] Drug Stock Dividends Wed 9:45am -
at TheStreet.com | | | PFE | | Israel Stocks: Israel stocks mixed; Compugen deal in focus Wed 9:45am -
at MarketWatch | | | PFE | | Compugen signs development deal with Pfizer Wed 8:24am -
AP | | | PFE | | UPDATE - Compugen says in collaboration deal with Pfizer Wed 8:06am -
at Reuters | | | PFE | | Medicines Co. Buys Heart Drug From Pfizer: BioBuzz Wed 7:59am -
at TheStreet.com | | | ANDS | | Anadys Drug Meets Key Study Goals Fri, Dec 18 -
Zacks.com | | | ANDS | | StockPreacher Initiates Independent Research Coverage for Anadys Pharmaceuticals Inc. Fri, Dec 18 -
GlobeNewswire | | | ANDS | | UPDATE - Anadys says hep C drug shows positive results in trial Thu, Dec 17 -
at Reuters | | | ANDS | | Anadys hepatitis C drug meets key study goals Thu, Dec 17 -
AP | | | ANDS | | Sequenom, Delta Petroleum: Early Volume Plays Thu, Dec 17 -
at TheStreet.com | | | ANDS | | ANA598 Demonstrates Positive 4-Week Results at 200 mg BID Thu, Dec 17 -
PR Newswire | | | DVAX | | Good News for Dynavax Fri, Dec 11 -
Zacks.com | | | DVAX | | DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Thu, Dec 10 -
EDGAR Online | | | DVAX | | Biotech Stocks: Drug stocks trend lower; Pfizer, Dynavax gain Wed, Dec 9 -
at MarketWatch | | | DVAX | | Dynavax gets OK at German factory for hepatitis vaccine work Wed, Dec 9 -
at bizjournals.com | | | DVAX | | Dynavax's European Manufacturing Facility Approved for Commercial Production of HEPLISAV Hepatitis B Surface Antigen Wed, Dec 9 -
Marketwire | | | DVAX | | DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Thu, Nov 19 -
EDGAR Online | | | All Headlines for these symbols... |
|
|
|